A new study from the University of Bologna is raising concerns about a common blood pressure medication and its impact on women’s heart health.
The research, published in the journal Hypertension, found that women with high blood pressure who take beta-blockers may face a higher risk of heart failure compared to men with similar health conditions—especially after a serious heart event.
Beta-blockers are often prescribed to people with high blood pressure, or hypertension, to reduce the risk of heart problems. But this study suggests that the effects of these drugs may not be the same for everyone.
The researchers focused on people who had high blood pressure but no history of heart disease. They especially looked at what happened after these individuals experienced a condition known as acute coronary syndrome, where blood flow to the heart is suddenly reduced. This can lead to heart attacks and other serious problems.
The study analyzed health data from 13,764 adults in 12 European countries. Everyone in the study had high blood pressure, but none had previously been diagnosed with heart disease. The participants were grouped by gender and whether or not they were taking beta-blockers.
The findings were eye-opening. Women who were on beta-blockers had a 4.6% greater chance of being hospitalized with heart failure after an acute coronary syndrome compared to men in the same situation.
The risk was even higher—6.1%—for women who had experienced a specific type of heart attack known as STEMI. This type of heart attack happens when a coronary artery is completely blocked and is considered one of the most dangerous.
One of the most concerning parts of the study was the difference in outcomes between those who developed heart failure and those who did not. People who developed heart failure had a death rate nearly seven times higher than those who had a heart attack without heart failure.
Interestingly, the risk of heart failure was nearly the same for men and women who were not taking beta-blockers. This suggests that the increased risk for women may be linked directly to the medication itself.
The study didn’t focus on why beta-blockers might affect women differently, but it hinted at some possible factors. For example, the interaction between beta-blockers and hormone replacement therapy—often used by postmenopausal women—could be playing a role. More research will be needed to explore this possibility.
These findings highlight the need for more personalized treatment plans, especially for women with high blood pressure. While beta-blockers can be effective for many people, they might not be the best option for everyone—especially women who have not had heart disease in the past.
Doctors often recommend lifestyle changes such as healthy eating, regular exercise, and stress management to help control blood pressure. This study supports that advice and adds that medications should be carefully chosen based on each person’s unique risks.
In short, this research is a wake-up call. It reminds us that women’s health often responds differently to treatments, and that medical care should take those differences into account. With more studies like this, the goal is to make blood pressure treatment safer and more effective for everyone.
If you care about heart health, please read studies that vitamin K helps cut heart disease risk by a third, and a year of exercise reversed worrisome heart failure.
For more health information, please see recent studies about supplements that could help prevent heart disease, stroke, and results showing this food ingredient may strongly increase heart disease death risk.
Copyright © 2025 Knowridge Science Report. All rights reserved.
